ArticleJournal of substance abuse treatment2022
The impact of COVID-19 on substance use disorder treatment in California: Service providers' perspectives.
Article in Journal of substance abuse treatment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 39 citations in OpenAlex.
- A longitudinal analysis of overall and telehealth addiction treatment utilization three years after pandemic-related policy changes.Journal of substance use and addiction treatment · 2026Article
- Delivering opioid use disorder treatment among American Indian and Alaska Native adults during the COVID-19 pandemic and beyond: Facilitators and barriers to care.Journal of ethnicity in substance abuse · 2025Article
- Referral of patients from rural primary care clinics to telemedicine vendors for opioid use disorder treatment: A mixed-methods study.Journal of telemedicine and telecare · 2025Article
- Features of drug addiction treatment programs in Atlantic Canada that help (or not) with access and retention: A qualitative study.PloS one · 2025Article
- Changes in Substance Use Diagnoses in the Great Plains during the COVID-19 Pandemic.Healthcare (Basel, Switzerland) · 2024Article
- Virtual focus groups among individuals with use disorders: assessing feasibility and acceptability in an underserved clinical population.Frontiers in psychiatry · 2024Article
- Lessons for future pandemics: Temporal evolution and rural-urban variations in the impacts of the COVID-19 on opioid use treatment.PloS one · 2024Article
- Perceptions of COVID-19 risk during the pandemic: perspectives from people seeking medication for opioid use disorder.Annals of medicine · 2023Article
- What can we learn from COVID-19 to improve opioid treatment? Expert providers respond.Journal of substance use and addiction treatment · 2023Article
- "Sign Me Up": a qualitative study of video observed therapy (VOT) for patients receiving expedited methadone take-homes during the COVID-19 pandemic.Addiction science & clinical practice · 2023Article
- Patient experiences of methadone treatment changes during the first wave of COVID-19: a national community-driven survey.Harm reduction journal · 2023Article
- Implementing an EMA burst design in community-engaged research: participant and researcher perspectives and recommendations.The American journal of drug and alcohol abuse · 2023Article
- A cohort study examining changes in treatment patterns for alcohol use disorder among commercially insured adults in the United States during the COVID-19 pandemic.Journal of substance abuse treatment · 2023Article
- Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States.Drug and alcohol dependence · 2023Review
- Ethical Dilemmas Facing Substance Use Counselors During the COVID-19 Pandemic.Substance abuse : research and treatment · 2023Review
- Lessons from the COVID-19 pandemic for substance misuse services: findings from a peer-led study.Harm reduction journal · 2022Article
- Reducing Problematic Substance Use under Exceptional Circumstances-Effects of the COVID-19 Restrictions on Inpatient Substance Use Disorder Treatment in Finland.International journal of environmental research and public health · 2022Article
- Telehealth-Based Delivery of Medication-Assisted Treatment for Opioid Use Disorder: a Critical Review of Recent Developments.Current psychiatry reports · 2022Review
- Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs.Harm reduction journal · 2022Article
- Insurance barriers to substance use disorder treatment after passage of mental health and addiction parity laws and the affordable care act: A qualitative analysis.Drug and alcohol dependence reports · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
backgroundThe COVID-19 pandemic has had a profound impact on the U.S. health care system, including addiction treatment. The objective of this study is to describe the impact of COVID on the delivery of treatment for substance use disorders (SUDs) from the perspectives of service providers.
methodsBetween May and September 2020, 61 service providers from 16 SUD treatment sites in California participated in virtual focus groups that lasted about an hour. We recorded the discussions and transcribed them verbatim. Two qualitative analysts independently conducted content analysis to identify themes from the transcripts.
resultsAt the beginning of the pandemic, service providers observed a slight decrease in patient admissions, followed by an uptick in patient flow due to increased mental health issues, alcohol use, and relapse. Many of the clinics adopted flexible service delivery modes, such as curbside dosing and extended take-home medication, to enable social distancing in clinic settings. Approximately half of the clinic encounters offered telemedicime, and a considerable proportion of patients preferred to use telephone-based services rather than video-based services. Internet instability and technical difficulties limited the use of telemedicine among their patients.
conclusionCOVID has been challenging for SUD treatment, but health care systems rapidly reacted with adjustments that may result in long-term changes in SUD service delivery. Telemedicine-based services have played a major role in ensuring uninterrupted patient care. Providers need organizational, technical, and logistical support to improve and sustain telemedicine services that increase access to quality care for their patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.